Research done at Penn CVI generally falls within one or more of these research programs.
Research at Penn Cardiovascular Institute (CVI) is organized into overlapping disease-focused research interests. All Penn CVI researchers, labs and activities fall within one or more of the following programs. Each of these research interests contribute to breakthroughs in the treatment and prevention of cardiovascular disease.
The Congenital Heart Disease and Development Research Program focuses on the genetic, molecular and translational research of congenital heart disease.
The Myocyte Biology and Heart Failure Research Program is focused on congestive heart failure and the pathophysiology of myocardial remodeling.
The Cardiac Electrophysiology Program is at the forefront of electrophysiology research, publishing extensive literature on the subject annually.
The Biotechnology and Imaging Program integrates physics, engineering, biophysics, imaging and other quantitative sciences into cardiovascular studies.
The Pulmonary Vascular Disease Program is focused on the mechanisms of a variety of diseases marked by pulmonary vascular dysfunction and pulmonary hypertension.
Congratulations to the 184 Penn physicians listed below who were included in Philadelphia Magazine's Top Doctors 2016.
Penn Medicine is one of the world’s leading academic medical centers.
A clinical trial is a research study involving patient volunteers that are conducted to find safe and effective treatments for a variety of health conditions.